Close Menu

NEW YORK (GenomeWeb) – Abbott said today that it has received World Health Organization prequalification approval for its m-Pima HIV-1/2 VL viral load diagnostic test, a portable molecular point-of-care platform for use in resource-limited settings such as in sub-Saharan Africa.

The m-Pima HIV-1/2 VL is a quantitative nucleic acid amplification test for viral load measurement in plasma samples of HIV type 1 groups M/N and O, and HIV-2.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new analysis finds some cancers receive more nonprofit dollars than others.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.